Inventor
MARK FITZGERALD
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes28%
A61BDiagnosis4%
A61MDevices for introducing media into, or onto, the body4%
PatentTitleYear
12,152,041Macrocyclic fluorine substituted indole derivatives202411,891,404Substituted macrocyclic indole derivatives202411,690,938Surgical system and method of use202311,492,358Macrocyclic indole derivatives202211,478,451Macrocyclic chlorine substituted indole derivatives202211,447,504Macrocyclic chlorine substituted indole derivatives202211,440,923Substituted macrocyclic indole derivatives202211,401,278Macrocyclic indole derivatives202211,286,263Macrocyclic fluorine substituted indole derivatives2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to BAYER AG (8)· patent assignee history
2022–2024Patents assigned to BROAD INST INC (8)· patent assignee history
2022–2024Patents assigned to Bayer Pharma AG (8)· patent assignee history
2022–2024Based in US· patent location history
2023Patents assigned to ALFRED HEALTH (1)· patent assignee history
2023Patents assigned to UNIV MONASH (1)· patent assignee history
2023Based in AU· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BAYER AG | 8 | 2022–2024 |
| BROAD INST INC | 8 | 2022–2024 |
| Bayer Pharma AG | 8 | 2022–2024 |
| ALFRED HEALTH | 1 | 2023 |
| UNIV MONASH | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2024 |
| AU | 1 | 2023 |